These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21720903)

  • 1. Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.
    Karakawa S; Okada S; Tsumura M; Mizoguchi Y; Ohno N; Yasunaga S; Ohtsubo M; Kawai T; Nishikomori R; Sakaguchi T; Takihara Y; Kobayashi M
    J Clin Immunol; 2011 Oct; 31(5):762-72. PubMed ID: 21720903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
    Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.
    Temmerman ST; Ma CA; Zhao Y; Keenan J; Aksentijevich I; Fessler M; Brown MR; Knutsen A; Shapiro R; Jain A
    J Clin Invest; 2012 Jan; 122(1):315-26. PubMed ID: 22156202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).
    Haverkamp MH; Marciano BE; Frucht DM; Jain A; van de Vosse E; Holland SM
    J Clin Immunol; 2014 May; 34(4):436-43. PubMed ID: 24682681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Izawa K; Murata Y; Tanaka N; Sakai H; Saito M; Yasumi T; Takaoka Y; Nakahata T; Mizukami T; Nunoi H; Kiyohara Y; Yoden A; Murata T; Sasaki S; Ito E; Akutagawa H; Kawai T; Imai C; Okada S; Kobayashi M; Heike T
    Blood; 2012 Jun; 119(23):5458-66. PubMed ID: 22517901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.
    Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F
    J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.
    Nishikomori R; Akutagawa H; Maruyama K; Nakata-Hizume M; Ohmori K; Mizuno K; Yachie A; Yasumi T; Kusunoki T; Heike T; Nakahata T
    Blood; 2004 Jun; 103(12):4565-72. PubMed ID: 14726382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.
    Pachlopnik Schmid JM; Junge SA; Hossle JP; Schneider EM; Roosnek E; Seger RA; Gungor T
    Pediatrics; 2006 May; 117(5):e1049-56. PubMed ID: 16636116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
    Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F
    J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
    Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
    Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis.
    Mancini AJ; Lawley LP; Uzel G
    Arch Dermatol; 2008 Mar; 144(3):342-6. PubMed ID: 18347290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation.
    Ørstavik KH; Kristiansen M; Knudsen GP; Storhaug K; Vege A; Eiklid K; Abrahamsen TG; Smahi A; Steen-Johnsen J
    Am J Med Genet A; 2006 Jan; 140(1):31-9. PubMed ID: 16333836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.
    Ma CA; Wang HY; Temmerman S; Zhao Y; Wu L; Hornung RL; Wara D; Jain A
    Hum Mutat; 2011 Mar; 32(3):318-24. PubMed ID: 21309033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.
    Hubeau M; Ngadjeua F; Puel A; Israel L; Feinberg J; Chrabieh M; Belani K; Bodemer C; Fabre I; Plebani A; Boisson-Dupuis S; Picard C; Fischer A; Israel A; Abel L; Veron M; Casanova JL; Agou F; Bustamante J
    Blood; 2011 Jul; 118(4):926-35. PubMed ID: 21622647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The range of defects associated with nuclear factor kappaB essential modulator.
    Uzel G
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):513-8. PubMed ID: 16264331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene.
    Mooster JL; Cancrini C; Simonetti A; Rossi P; Di Matteo G; Romiti ML; Di Cesare S; Notarangelo L; Geha RS; McDonald DR
    J Allergy Clin Immunol; 2010 Jul; 126(1):127-32.e7. PubMed ID: 20542322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO.
    Carrol ED; Gennery AR; Flood TJ; Spickett GP; Abinun M
    Arch Dis Child; 2003 Apr; 88(4):340-1. PubMed ID: 12651765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levels.
    Karamchandani-Patel G; Hanson EP; Saltzman R; Kimball CE; Sorensen RU; Orange JS
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):50-6. PubMed ID: 21704885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.